Skip to main content

Table 2 Differences between the interventions that the participants wanted to use and the interventions that they actually used after the travel consultations

From: Characteristics and potential quality indicators for evaluating pre-travel consultations in Japan hospitals: the Japan Pretravel consultation registry (J-PRECOR)

 

Vaccines and prescriptions that the participants wanted to use themselves

Vaccines and prescriptions actually given after pre-travel consultation

*Percentage difference

**Change ratio

***P value

Hepatitis A vaccine

3946

5655

17.6

1.43

< 0.001

Hepatitis B vaccine

2562

2961

4.1

1.16

< 0.001

Rabies vaccine

2804

3209

4.2

1.14

< 0.001

Vaccines containing tetanus toxoid

3017

4625

16.6

1.53

< 0.001

Tdap

151

597

4.6

3.95

< 0.001

DTaP

471

2388

19.8

5.07

< 0.001

Typhoid fever vaccine

1513

2468

9.8

1.63

< 0.001

Japanese encephalitis vaccine

1231

1745

5.3

1.42

< 0.001

Meningococcal ACWY vaccine

463

772

3.2

1.67

< 0.001

Meningococcal B vaccine

8

32

0.2

4.00

< 0.001

Vaccines containing measles

772

2012

12.8

2.61

< 0.001

Vaccines containing rubella

682

2006

13.6

2.94

< 0.001

Yellow fever vaccine

3014

3559

5.6

1.18

< 0.001

Prophylaxis for acute altitude sickness

338

370

0.3

1.09

< 0.05

Prophylaxis for malaria

1146

1252

1.12

1.10

< 0.001

  1. *Percentage difference: percentage after pretravel consultations minus that before pretravel consultations (after - before)
  2. **Change ratio: Ratio of the number of cases after pretravel consultations to that before pretravel consultations (after/ before)
  3. ***Compared using the McNemar test